Fixed-Dose Combination Therapy in Hypertension: Cons

By Angeli Fabio  

High Blood Pressure & Cardiovascular Prevention, Vol. 19, Iss. 2, 2012-06 ,pp. : 51-54

Adis International

Access to resources Recommend Favorite

The Role of Fixed-Dose Combination Therapy with Drugs that Target the Renin-Angiotensin System in the Hypertension Paradigm

By Schmieder Roland E.  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 35-42

Informa Healthcare

Access to resources Recommend Favorite

Three-Year Safety and Effectiveness of Fixed-Dose Losartan/Hydrochlorothiazide Combination Therapy in Japanese Patients with Hypertension Under Clinical Setting (PALM-1 Extension Study)

By Kita Toshihiro   Yokota Naoto   Ichiki Yoshinari   Ayabe Takao   Etoh Takuma   Tamaki Noboru   Kato Johji   Eto Tanenao   Kitamura Kazuo  

Clinical and Experimental Hypertension, Vol. 34, Iss. 7, 2012-11 ,pp. : 498-503

Informa Healthcare

Access to resources Recommend Favorite

Nebivolol/Hydrochlorothiazide: A New Fixed-Dose Combination for Effective Simplified Antihypertensive Therapy

By Malacco Ettore  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 2, 2008-01 ,pp. : 75-84

Adis International

Access to resources Recommend Favorite

An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in Chinese patients with mild to moderate hypertension

By Ueng Kwo-Chang   Lin Lung-Chun   Voon Wen-Chol   Lin Ming-Cheng   Liu Yen-Bin   Su Ho-Ming   Chang Po-Yuan   Lin Tsung-Hsien   Chen Wei-Liang   Wu Chau-Chung   Lai Wen-Ter   Lin Chung-Sheng  

Blood Pressure, Vol. 17, Iss. 1, 2008-06 ,pp. : 24-31

Informa Healthcare

Access to resources Recommend Favorite